Go Deep
Unichem Laboratories Limited
Unichem Laboratories Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 24,143 | 12.2 | 1.36 | 0.18 | 526.35 |
Unichem Laboratories Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 6,326,200,000.0 | 5,751,200,000.0 | 5,211,700,000.0 | 5,789,600,000.0 |
| Net Profit | 414,700,000.0 | 109,100,000.0 | 2,642,900,000.0 | -118,900,000.0 |
| EPS | 5.9 | 1.6 | 37.5 | -1.7 |
Unichem Laboratories Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 21,594,100,000.0 | 20,644,800,000.0 | 17,376,300,000.0 | 13,024,201,000.0 | — |
| Net Profit | 2,528,400,000.0 | 1,375,200,000.0 | -937,600,000.0 | -2,022,276,000.0 | — |
| EPS | 35.9 | 19.5 | -13.3 | -28.7 | — |
Unichem Laboratories Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 37,374,400,000.0 | 35,694,000,000.0 | 32,749,500,000.0 | 31,930,489,000.0 | — |
| Total Liabilities | 10,200,000,000.0 | 11,188,100,000.0 | 8,366,500,000.0 | 7,577,448,000.0 | — |
| Total Equity | 27,174,400,000.0 | 24,505,900,000.0 | 24,383,000,000.0 | 24,353,041,000.0 | — |
Owes vs Owns
Unichem Laboratories Limited owed ₹0.27 for every ₹1 it owned in Mar 2026, up from ₹0.24 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.27× | 0.31× | 0.26× | 0.24× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Unichem Laboratories Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 7.7%Receivables 22.2%Inventory 26.1%Fixed assets (tangible) 35.3%Other assets 8.5%
How it's funded — Mar 2026
Short-term debt 11.5%Long-term debt 1.0%Payables 9.5%Other liabilities 5.2%Shareholders' equity 72.7%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 289.5 | 89.6 | 156.1 | 185.3 |
| Receivables | 828.6 | 778.8 | 642.3 | 588.6 |
| Inventory | 975.0 | 988.7 | 736.3 | 625.2 |
| Fixed assets (tangible) | 1,319.0 | 1,331.3 | 1,324.3 | 1,409.3 |
| Intangible assets | 8.9 | 20.2 | 57.9 | 1.5 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 316.5 | 360.7 | 358.1 | 383.1 |
| Liabilities & equity | ||||
| Short-term debt | 429.7 | 369.2 | 180.9 | 233.7 |
| Long-term debt | 39.1 | 60.8 | 38.2 | 63.6 |
| Payables | 356.6 | 386.9 | 351.3 | 290.7 |
| Other liabilities | 194.6 | 301.9 | 266.2 | 169.7 |
| Shareholders' equity | 2,717.4 | 2,450.6 | 2,438.3 | 2,435.3 |
| Net tangible assets | 2,708.6 | 2,430.3 | 2,380.4 | 2,433.8 |
Unichem Laboratories Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 36,400,000.0 | -70,200,000.0 | 140,000,000.0 | -850,907,000.0 | — |
| Investing Activities | 1,920,600,000.0 | -2,412,300,000.0 | 504,000,000.0 | 2,028,133,000.0 | — |
| Financing Activities | 18,600,000.0 | 1,837,600,000.0 | -1,063,100,000.0 | -812,999,000.0 | — |